NovaBay Pharma (NBY) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $0.08 --0%
Revenue Growth %: -14.6%
Financial Fact:
Total operating expenses: 4.89M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: -14.6%
Financial Fact:
Total operating expenses: 4.89M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $90 thousand versus the consensus estimate of $200 thousand.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TechnipFMC (FTI) Tops Q1 EPS by 6c, provides guidance
- Pool Corp. (POOL) Misses Q1 EPS by 1c; beats on guidance
- Expro Group Holdings N.V. (XPRO) Reports In-Line Q1 EPS, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
